具体描述
This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.New chapters cover: ULLIthe marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliance/LILIpharmacovigilance programs designed to prevent widespread safety issues/LILIlegal issues surrounding the sourcing of foreign APIs/LILIthe issues of counterfeit drugs/LILIupdates on quality standards/LI/UL
作者简介
目录信息
读后感
评分
评分
评分
评分
用户评价
相关图书
本站所有内容均为互联网搜索引擎提供的公开搜索信息，本站不存储任何数据与内容，任何内容与数据均与本站无关，如有需要请联系相关搜索引擎包括但不限于百度，google,bing,sogou 等
© 2025 book.quotespace.org All Rights Reserved. 小美书屋 版权所有